In this episode, I had a compelling conversation with Dr. Angie Landeros-Weisenberger, an Associate Research Scientist at the Yale Child Study Center. We discuss the current state of research and the latest breakthroughs in treating tics and co-occurring conditions such as OCD and depression. Dr. Angie's expertise and passion for research left me both inspired and hopeful for what's on the horizon in patient care.
Episode Highlights:
[01:30] - Dr. Angie’s history of research.
[02:39] - Innovative treatments on the horizon.
[06:10] - Exploring genetic mysteries of tics.
[09:37] - Breaking the habit loop.
[13:33] - The future of wearables.
[16:18] - Trichotillomania research and why it’s not a tic disorder.
[18:48] - Gender bias in tic diagnosis.
[20:46] - A lifetime with OCD and tics.
[24:33] - Selective serotonin reuptake inhibitors (SSRIs) treatment for OCD.
[27:09] - Science is not set in stone, changes will occur with more research.
[27:25] - Advances in research of tools, such as ketamine, for treatment-resistant depression.
[31:34] - Very promising things are coming through research and studies.
Links & Resources:
Yale Child Study Center: https://medicine.yale.edu/childstudy/
New Jersey Center for Tourette Syndrome and Associated Disorders (NJCTS): https://njcts.org/
I want to remind all our listeners that each episode we share is a stepping stone to better understanding the intricate world of Tourette Syndrome and related disorders. If you've enjoyed today's episode, rate us and leave a review. Your feedback not only supports the show but also helps us reach and educate more people like you.
Send us a text

Support the show